Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
NVCR
Stock Latest News
Market News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
2d ago
MU
AMD
Premium
The Fly
Midday Fly By: Cisco reports Q2 beat, Trump orders Pentagon to buy coal
2d ago
BAX
BTU
Premium
The Fly
Unusually active option classes on open February 12th
2d ago
BP
MU
Premium
Market News
Why Is NovoCure Stock (NVCR) Up Today?
2d ago
NVCR
Premium
The Fly
Novocure price target raised to $47 from $39 at H.C. Wainwright
2d ago
NVCR
Premium
The Fly
Novocure’s Optune Pax approved by FDA to treat pancreatic cancer
3d ago
NVCR
Premium
Company Announcements
Novocure Wins FDA Approval for Optune Pax in Pancreatic Cancer
3d ago
8K
NVCR
Premium
Ratings
Maintaining Buy on NovoCure: Viewing CMS Billing Revocation as a Temporary Administrative Setback with Limited Long-Term Impact
9d ago
NVCR
Premium
Company Announcements
NovoCure Faces CMS Billing Revocation, Revenue Impact Uncertain
9d ago
8K
NVCR
Premium
The Fly
Novocure price target lowered to $39 from $42 at H.C. Wainwright
1M ago
NVCR
Premium
The Fly
Novocure reports preliminary Q4 revenue $174.4M, consensus $168.93M
1M ago
NVCR
Premium
The Fly
Novocure price target lowered to $20 from $22 at Evercore ISI
1M ago
NVCR
Premium
Ratings
NovoCure’s Strategic Leadership and Product Developments Drive Buy Rating
3M ago
NVCR
Premium
Company Announcements
NovoCure Appoints Frank Leonard as New CEO
3M ago
8K
NVCR
Premium
The Fly
Novocure CEO Ashley Cordova resigns, Frank Leonard succeeds
3M ago
NVCR
Premium
Company Announcements
NovoCure’s Mixed Q3: Growth Amid Challenges
4M ago
NVCR
Premium
Company Announcements
Novocure Ltd. Reports Q3 2025 Financial Results
4M ago
NVCR
Premium
The Fly
Novocure price target raised to $42 from $38 at H.C. Wainwright
4M ago
NVCR
Premium
The Fly
Novocure reports Q3 EPS (33c), consensus (42c)
4M ago
NVCR
Premium
The Fly
Novocure reports Q3 EPS (33c), consensus (42c)
4M ago
NVCR
Premium
Pre-Earnings
NVCR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
NVCR
Premium
Company Announcements
NovoCure’s Phase 3 Glioblastoma Study: A Potential Game-Changer in Cancer Treatment
4M ago
NVCR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
